Abstract
A series of pyrazinones were prepared and evaluated as potential CRF1R PET imaging agents. Optimization of their CRF1R binding potencies and octanol–phosphate buffer phase distribution coefficients are discussed herein.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have